Furthermore, eTRC appeared to be as effective as conventional dieting for the management of multiple cardiometabolic risk factors, encompassing overweight, increased whole-body and visceral adiposity, insulin resistance, impaired insulin clearance and dyslipidaemia. This evidence concerns the gene INS and Insulin resistance.